Loading...
review article
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014
Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers, are very productive. The review "Drugs interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs" was accepted in October 2012. In the last 20 months, new targets for the potential treatment of Alzheimer's disease were identified. Enormous progress was realized in the pharmacological characterization of natural products with cognitive enhancing properties. This review covers the evolution of research in this field through May 2014.
Type
review article
Web of Science ID
WOS:000343763000003
Authors
Publication date
2014
Publisher
Published in
Volume
42
Issue
4
Start page
1079
End page
1149
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
December 30, 2014
Use this identifier to reference this record